E-pharmacy market seen topping $366 billion by 2030

The Business Research Company projects the global e-pharmacy market will surpass $366 billion by 2030, driven by rising internet and smartphone use, telehealth adoption and demand for home delivery. CVS Health led the market in 2025 with a 16% share, while Asia Pacific is expected to become the largest regional market.

Why it matters: - E-pharmacy is moving from a convenience play to a major channel for medication access. - The market’s projected growth to more than $366 billion by 2030 signals continued pressure on traditional pharmacy models. - Patients, insurers and health systems are increasingly using digital refill, delivery and verification tools to cut friction in prescription access.

What happened: - The Business Research Company released its E-Pharmacy Global Market Report 2026 with forecasts through 2035. - The report projects the global e-pharmacy market will exceed $366 billion by 2030. - The market is forecast to grow at a 23% compound annual growth rate through 2030. - CVS Health held a 16% share of the market in 2025, according to the report. - The top 10 companies accounted for 22% of revenue in 2025. - Asia Pacific is projected to become the largest regional market by 2030. - The United States is projected to remain the largest single-country market by 2030.

The details: - Asia Pacific is forecast to reach $125.7 billion by 2030, up from $41.1 billion in 2025, implying 25% annual growth. - The U.S. market is projected to reach $97.6 billion by 2030, up from $41.4 billion in 2025, at a 19% CAGR. - Prescription drugs are expected to represent 70% of the market, or $254 billion, by 2030. - The report also tracks skincare, dental care, cold and flu remedies, vitamins and weight loss products. - Payment models include cash on delivery and online payment. - Platform formats include app-based and web-based services. - CVS Health’s digital pharmacy offering includes prescription management, medication delivery and online healthcare services. - Walgreens Company ranked second in 2025 with a 6% share. - Amazon Pharmacy, Express Scripts, OptumRx, DocMorris, PharmEasy, Tata 1mg, Apollo Pharmacy and Walmart were also listed among the leading companies. - The report names major suppliers including Pfizer, Novartis, Johnson & Johnson Innovative Medicine, Roche, Merck, AstraZeneca, GSK, Sanofi and Eli Lilly. - It also lists distributors including McKesson, Cencora, Cardinal Health, Medline, McKesson-affiliated units and multiple regional pharmacy wholesalers. - End users cited in the report include Amazon Pharmacy, CVS Health, Walgreens Boots Alliance, Cigna, Aetna, Capsule, GoodRx, Truepill, Shop Apotheke Europe and Pharmacy2U. - The report says its 2026 editions include market attractiveness scoring, TAM analysis, company scoring matrices, forecasting dashboards, market hotspot graphics and updated trend analysis. - The Business Research Company says it draws on more than 30,000 reports across 27 industries and more than 60 geographies.

Between the lines: - The growth story is being driven by a mix of structural and behavioral shifts, not a single product cycle. - Higher internet and smartphone penetration, telemedicine integration and digital payment tools are lowering the barrier to online medicine purchases. - Chronic disease management and aging populations are increasing the need for recurring, reliable delivery. - The market remains moderately fragmented, which suggests scale, regulation and logistics are still key competitive advantages. - Integrated digital pharmacy platforms appear to be the clearest strategic response for large players trying to lock in patients. - Eli Lilly’s January 2024 launch of LillyDirect shows how pharma companies are blending telehealth consultations with direct medication delivery.

What's next: - E-pharmacy operators are expected to keep investing in AI-driven recommendations, prescription workflow automation and inventory management. - Companies are likely to expand last-mile delivery capabilities and secure payment systems as competition intensifies. - Further growth should come from prescription refills, chronic care and telehealth-linked medication ordering. - The report suggests online and app-based pharmacy models will keep taking share as consumers prioritize convenience and price transparency.

The bottom line: - E-pharmacy is becoming a core healthcare access channel, with the biggest gains likely to come from prescription drugs, digital care integration and delivery networks.